SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-018551
Filing Date
2020-04-24
Accepted
2020-04-24 16:51:02
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 bioc-s3.htm S-3 557175
2 EX-4.2 bioc-ex42_61.htm EX-4.2 4277
3 EX-4.23 bioc-ex423_17.htm EX-4.23 442876
4 EX-4.26 bioc-ex426_15.htm EX-4.26 148407
5 EX-4.27 bioc-ex427_14.htm EX-4.27 143999
6 EX-4.28 bioc-ex428_18.htm EX-4.28 130613
7 EX-5.1 bioc-ex51_19.htm EX-5.1 39963
8 EX-23.1 bioc-ex231_16.htm EX-23.1 2791
9 GRAPHIC g04tkshabgzx000001.jpg GRAPHIC 52033
10 GRAPHIC g04tkshabgzx000002.jpg GRAPHIC 42104
  Complete submission text file 0001564590-20-018551.txt   1600947
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237837 | Film No.: 20815745
SIC: 8071 Services-Medical Laboratories